BUB1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.818200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.482200E-01
Normal-vs-Stage2
4.131800E-01
Normal-vs-Stage3
9.997000E-01
Normal-vs-Stage4
6.876600E-01
Stage1-vs-Stage2
2.984600E-01
Stage1-vs-Stage3
9.365800E-01
Stage1-vs-Stage4
6.866000E-01
Stage2-vs-Stage3
3.439400E-01
Stage2-vs-Stage4
7.249200E-01
Stage3-vs-Stage4
6.142400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.698000E-01
Normal-vs-AfricanAmerican
6.430600E-01
Normal-vs-Asian
6.305400E-01
Caucasian-vs-AfricanAmerican
7.083200E-01
Caucasian-vs-Asian
5.021800E-01
AfricanAmerican-vs-Asian
8.820600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.712600E-01
Normal-vs-Female
4.979400E-01
Male-vs-Female
8.160200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.183400E-01
Normal-vs-Age(41-60Yrs)
4.294400E-01
Normal-vs-Age(61-80Yrs)
5.169800E-01
Normal-vs-Age(81-100Yrs)
4.045600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.961200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.129400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.782600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.973960E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.838200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.661600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.921800E-01
Normal-vs-Daily Drinker
5.234000E-01
Normal-vs-Weekly Drinker
5.061400E-01
Normal-vs-Occasional Drinker
3.893400E-01
Normal-vs-Social Drinker
5.055000E-01
Non Drinker-vs-Daily Drinker
9.216800E-01
Non Drinker-vs-Weekly Drinker
4.392000E-01
Non Drinker-vs-Occasional Drinker
4.469000E-01
Non Drinker-vs-Social Drinker
8.103000E-01
Daily Drinker-vs-Weekly Drinker
5.460000E-01
Daily Drinker-vs-Occasional Drinker
5.005400E-01
Daily Drinker-vs-Social Drinker
8.737600E-01
Weekly Drinker-vs-Occasional Drinker
8.796400E-01
Weekly Drinker-vs-Social Drinker
6.302400E-01
Occasional Drinker-vs-Social Drinker
6.530000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.838600E-01
Normal-vs-Grade 2
6.616800E-01
Normal-vs-Grade 3
7.025800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.792600E-04
Grade 1-vs-Grade 3
4.20939999999925E-05
Grade 1-vs-Grade 4
5.838600E-01
Grade 2-vs-Grade 3
1.263810E-01
Grade 2-vs-Grade 4
6.616800E-01
Grade 3-vs-Grade 4
7.025800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.095400E-01
Normal-vs-NonDiabetic
4.724600E-01
Diabetic-vs-NonDiabetic
5.451000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.585800E-01
Normal-vs-NoPancreatitis
5.206200E-01
Pancreatitis-vs-NoPancreatitis
6.269200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.251600E-01
Normal-vs-N1
4.381000E-01
N0-vs-N1
3.440200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.164400E-02
Normal-vs-TP53-NonMutant
6.563000E-01
TP53-Mutant-vs-TP53-NonMutant
8.99759999839489E-08
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
